-
Information-Publications
-
SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitopeDetails -
Salivary Gland Protective and Anti-Inflammation Effects of Genistein in Sjögren's Syndrome by Inhibiting Xist/Acsl4-Mediated Ferroptosis Following Binding to …Details -
Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing ToolDetails -
Tight Junction Component Occludin Binds to FIP5 to Regulate Endosome Trafficking and Mitotic Spindle FunctionDetails -
AutoDock and molecular dynamics-based therapeutic potential prediction of flavonoids for primary Sjögren's syndromeDetails -
Targeting Tumor Heterogeneity by Breaking a Stem Cell and Epithelial Niche Interaction LoopDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
